
Axon Neuroscience has announced data from its Phase 2 trial ADAMANT for the first-in-class vaccine AADvac1 to slow the progression …

Scientists at the University of Washington have developed a gene therapy that prevents the process through which axons (nerve fibres) …

UK healthcare comms and PR firm AXON Communications has added five new members to its team in London. Lucie Burns …

Paul Jacobs has joined digital and social agency Sonic Boom Creative Media, a sister agency of AXON Communications, as director, …

Surrey, UK-based communications agency Axon has appointed Natalie Henson as associate director. She re-joins the firm in a leadership role …

Surrey, UK-based Axon Communications has appointed Mario Nacinovich as managing director of its new US operations. Nacinovich will be based …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

